Literature DB >> 8126203

Evaluation of a new immunodiagnostic assay for Helicobacter pylori antibody detection: correlation with histopathological and microbiological results.

A D Pronovost1, S L Rose, J W Pawlak, H Robin, R Schneider.   

Abstract

Infection with Helicobacter pylori has been associated with the pathogenesis of chronic active gastritis and gastric and duodenal ulcer disease. Detection of immunoglobulin G antibodies to H. pylori offers a simple alternative to direct detection of the organism in biopsied tissue by culture or histopathological methods. A rapid flow-through membrane-based enzyme immunoassay for the detection of human immunoglobulin G antibodies to H. pylori has been developed and evaluated. Clinical evaluations were performed with 256 patient serum samples obtained from four clinical sites. Biopsy samples were obtained by endoscopic procedures at the same time as the serum samples, and were histopathologically and microbiologically categorized for the presence or absence of H. pylori. Sensitivity and specificity for this rapid enzyme immunoassay were 92 and 88%, respectively, compared directly with endoscopy results. After discordant results were resolved by a quantitative microwell enzyme-linked immunosorbent assay, the resulting sensitivity and specificity were 94 and > 99%, respectively. These results indicate that this rapid enzyme immunoassay is a useful technique to determine H. pylori infection status and is a viable alternative to invasive endoscopic procedures.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8126203      PMCID: PMC262967          DOI: 10.1128/jcm.32.1.46-50.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons.

Authors:  C P Dooley; H Cohen; P L Fitzgibbons; M Bauer; M D Appleman; G I Perez-Perez; M J Blaser
Journal:  N Engl J Med       Date:  1989-12-07       Impact factor: 91.245

2.  Seroepidemiology of Campylobacter pylori infection in various populations.

Authors:  F Mégraud; M P Brassens-Rabbé; F Denis; A Belbouri; D Q Hoa
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

3.  Kinetics of specific IgG antibodies for monitoring the effect of anti-Helicobacter pylori chemotherapy.

Authors:  A M Hirschl; G Brandstätter; B Dragosics; E Hentschel; M Kundi; M L Rotter; K Schütze; M Taufer
Journal:  J Infect Dis       Date:  1993-09       Impact factor: 5.226

4.  Enzyme-linked immunosorbent assay for Campylobacter pyloridis: correlation with presence of C. pyloridis in the gastric mucosa.

Authors:  C S Goodwin; E Blincow; G Peterson; C Sanderson; W Cheng; B Marshall; J R Warren; R McCulloch
Journal:  J Infect Dis       Date:  1987-03       Impact factor: 5.226

5.  Campylobacter pylori antibodies in humans.

Authors:  G I Perez-Perez; B M Dworkin; J E Chodos; M J Blaser
Journal:  Ann Intern Med       Date:  1988-07-01       Impact factor: 25.391

6.  Seroepidemiology of Campylobacter pyloridis.

Authors:  A Morris; G Nicholson; G Lloyd; D Haines; A Rogers; D Taylor
Journal:  N Z Med J       Date:  1986-09-10

7.  Pyloric Campylobacter infection and gastroduodenal disease.

Authors:  B J Marshall; D B McGechie; P A Rogers; R J Glancy
Journal:  Med J Aust       Date:  1985-04-15       Impact factor: 7.738

8.  Intrafamilial clustering of Helicobacter pylori infection.

Authors:  B Drumm; G I Perez-Perez; M J Blaser; P M Sherman
Journal:  N Engl J Med       Date:  1990-02-08       Impact factor: 91.245

9.  Growth of Campylobacter pylori in liquid media.

Authors:  D R Morgan; R Freedman; C E Depew; W G Kraft
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

10.  Evaluation of techniques for isolation, subcultivation, and preservation of Helicobacter pylori.

Authors:  R Ansorg; G Von Recklinghausen; R Pomarius; E N Schmid
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

View more
  18 in total

Review 1.  Evaluation of commercially available Helicobacter pylori serology kits: a review.

Authors:  R J Laheij; H Straatman; J B Jansen; A L Verbeek
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

2.  Helicobacter pylori in Dyspepsia - Antibiotic Sensitivity and Virulence Patterns.

Authors:  R N Misra; M Bhagat; N Ahmed
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  17 β-estradiol suppresses Helicobacter pylori-induced gastric pathology in male hypergastrinemic INS-GAS mice.

Authors:  Masahiro Ohtani; Zhongming Ge; Alexis García; Arlin B Rogers; Sureshkumar Muthupalani; Nancy S Taylor; Shilu Xu; Koichiro Watanabe; Yan Feng; Robert P Marini; Mark T Whary; Timothy C Wang; James G Fox
Journal:  Carcinogenesis       Date:  2011-05-11       Impact factor: 4.944

4.  Brugia filariasis differentially modulates persistent Helicobacter pylori gastritis in the gerbil model.

Authors:  Heather R Martin; Krishna P Shakya; Sureshkumar Muthupalani; Zhongming Ge; Thomas R Klei; Mark T Whary; James G Fox
Journal:  Microbes Infect       Date:  2010-05-31       Impact factor: 2.700

5.  Antibody response of patients with Helicobacter pylori-related gastric adenocarcinoma: significance of anti-cagA antibodies.

Authors:  C Vaucher; B Janvier; J B Nousbaum; B Grignon; L Pezennec; M Robaszkiewicz; H Gouerou; B Picard; J L Fauchere
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

Review 6.  Role of Helicobacter pylori in gastrointestinal disease: implications for primary care of a revolution in management of dyspepsia.

Authors:  B C Delaney
Journal:  Br J Gen Pract       Date:  1995-09       Impact factor: 5.386

7.  Immune responses to differentiated forms of Helicobacter pylori in children with epigastric pain.

Authors:  Bee Ling Ng; Seng Hock Quak; Marion Aw; Kee Tai Goh; Bow Ho
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

8.  Inflammation and foveolar hyperplasia are reduced by supplemental dietary glutamine during Helicobacter pylori infection in mice.

Authors:  Susan J Hagen; Masa Ohtani; Jin-Rong Zhou; Nancy S Taylor; Barry H Rickman; George L Blackburn; James G Fox
Journal:  J Nutr       Date:  2009-03-04       Impact factor: 4.798

9.  Cross-reactivity between immune responses to Helicobacter bilis and Helicobacter pylori in a population in Thailand at high risk of developing cholangiocarcinoma.

Authors:  Paola Pisani; Mark T Whary; Ingrid Nilsson; Supannee Sriamporn; Torkel Wadström; James G Fox; Asa Ljungh; David Forman
Journal:  Clin Vaccine Immunol       Date:  2008-07-02

10.  Concurrent Helicobacter bilis infection in C57BL/6 mice attenuates proinflammatory H. pylori-induced gastric pathology.

Authors:  Laura B Lemke; Zhongming Ge; Mark T Whary; Yan Feng; Arlin B Rogers; Sureshkumar Muthupalani; James G Fox
Journal:  Infect Immun       Date:  2009-02-17       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.